Poultry Medicine Market Size, Share & Trends Analysis Report By Species (Chicken, Turkey, Ducks), By Product (Biologics, Pharmaceuticals), By Disease, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033

Poultry Medicine Market Summary

The global poultry medicine market size was estimated at USD 6.72 billion in 2024 and is projected to reach USD 11.90 billion by 2033, growing at a CAGR of 6.70% from 2025 to 2033. The market is advancing, driven by the growing prevalence of poultry diseases, rising demand for poultry products, and expansion of commercial poultry farming.

The frequent occurrence of poultry diseases like avian influenza, Newcastle disease, and infectious bronchitis has significantly increased the demand for effective pharmaceuticals. According to the Food and Agriculture Organization of U.S., as of April 2025, a total of 297 outbreaks or events of Highly Pathogenic Avian Influenza (HPAI) in poultry animals have been reported across five geographic regions.

Outbreaks of infectious diseases significantly impact poultry mortality and productivity. These recurrent health threats drive a strong demand for vaccines, antimicrobials, and antiparasitic treatments to protect flocks and reduce losses. Governments and producers are investing in better biosecurity and routine health management practices, creating consistent demand for poultry medicines. With the rise in intensive poultry farming and high bird densities, the risk of disease transmission grows, making regular medicinal interventions critical. This need for consistent health protection fuels steady growth in the market across all production scales.The World Organization for Animal Health (WOAH), an international body that sets global standards for animal health and monitors disease outbreaks to improve animal welfare and public health, conducted surveillance activities for Highly Pathogenic Avian Influenza (HPAI) in both poultry and non-poultry bird populations in the period of 2020-2023. The chart below illustrates the reporting of avian disease across various regions:

The growing prevalence of diseases can cause substantial economic losses due to decreased productivity, high mortality rates, and trade restrictions. As a result, poultry farmers and producers are increasingly reliant on vaccines, antibiotics, and antiparasitics to prevent and control outbreaks. The growing emphasis on biosecurity measures and disease management protocols has further propelled the use of pharmaceutical products to ensure flock health, safeguard food supply chains, and maintain regulatory compliance in both domestic and international markets.

Another significant factor is the increasing global consumption of poultry meat and eggs, which is driving the poultry pharmaceuticals industry. As consumers shift toward leaner protein sources, poultry has become a preferred option due to its affordability, taste, and perceived health benefits. This surge in demand necessitates large-scale poultry farming, which in turn drives the need for medicines to maintain flock health, prevent disease outbreaks, and ensure high productivity. Countries experiencing economic growth and urbanization are particularly fuelling this trend, boosting investments in veterinary drugs, vaccines, and feed additives specific to poultry health.

The shift from traditional backyard poultry farming to large-scale, industrialized operations has increased the need for systematic health management, fuelling demand for medicines. Commercial poultry farms operate under high-density conditions that elevate the risk of disease transmission, making preventive care and routine medication essential. These operations often rely on integrated health management strategies that include vaccinations, growth promoters, and disease control agents, ensuring flock health and productivity. The growth of vertically integrated poultry producers, especially in emerging economies, further stimulates demand for consistent and regulated pharmaceutical solutions.

Global Poultry Medicine Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global poultry medicine market report based on species, product, disease, route of administration, distribution channel, and region.

• Species Outlook (Revenue, USD Million, 2021 - 2033)
• Chicken
• Broiler
• Layer
• Turkey
• Ducks
• Others
• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Biologics
• Vaccines
• Modified/ Attenuated Live
• Inactivated (Killed)
• Other Vaccines
• Other Biologics
• Pharmaceuticals
• Parasiticides
• Anti-infectives
• Anti-inflammatory
• Analgesics
• Others
• Medicated Feed Additives
• Disease Outlook (Revenue, USD Million, 2021 - 2033)
• Newcastle Disease
• Infectious Bronchitis
• Infectious Bursal Disease
• Coccidiosis
• Salmonella
• Marek's Disease
• Others
• Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
• Oral
• Injectable
• Topical
• Others
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Veterinary Hospitals & Clinics
• E-commerce
• Offline Retail Stores
• Others
• Regional Outlook (Revenue, USD Million, 2021- 2033)
• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Rest of Europe
• Asia Pacific
• Japan
• India
• China
• South Korea
• Australia
• Thailand
• Rest of APAC
• Latin America
• Brazil
• Argentina
• Rest of LATAM
• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Rest of MEA

Please note The report will be delivered in 2-3 business days upon order notification. Show more